February 2025 FDA Recall Drug by Turbare Manufacturing
D-0248-2025 - Lack of Assurance of Sterility
This Class II drug recall was voluntarily initiated by Turbare Manufacturing on February 18, 2025 for the product Drug. The FDA reported the reason for recall as lack of assurance of sterility. The product was distributed Nationwide and the recall is currently completed.
Recall Number: D-0248-2025
Lack of Assurance of Sterility: due to a quality control process deviation
02-18-2025
03-05-2025
1,147 syringes
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Completed
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Turbare Manufacturing
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Nationwide in the USA
02-26-2026
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Avastin 1.25 mg/0.05 mL in 0.25 mL Syringe, For Intravitreal Injection Only, Office Use Only - Not for Resale - Single Use, This drug product was repackaged by Turbare Manufacturing, 925 Jeanette Drive, Conway, AR 72032, NDC: 83556-0101-01.
Batch or Lot Expiration Information
Lot# s: 12122024@2 (BUD: 3/12/2025); 12192024@2 (BUD: 4/18/2025).